CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 27 enrolled
Drug / intervention
Alendronatedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02139007
NCT02139007Phase 4Completed
CompareCT.gov

Effectiveness of DiscontinuinG bisphosphonatEs Study: R21 Pilot Study

University of Alabama at Birmingham·interventional·Posted May 15, 2014·Updated May 12, 2017

In Brief

A Phase 4 clinical trial evaluating Alendronate for Osteoporosis. Completed, enrolled 27 participants across 1 site.

Detailed Summary

This is a pilot study evaluating the recruitment strategies for sites and patients, data collection instruments, follow-up procedures, administrative processes, and the proposed management strategy for the future large scale national trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoporosis
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 15, 2014
Enrollment StartJun 1, 2014
Primary CompletionJun 1, 2016
Study CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 12.1 years ago

Interventions

Alendronatedrug